CLIFX | MVCAX | CLIFX / MVCAX | |
Total Expense Ratio | 0.90 | 0.99 | 91% |
Annual Report Gross Expense Ratio | 1.17 | 1.00 | 117% |
Fund Existence | 12 years | 24 years | - |
Gain YTD | 14.893 | 5.737 | 260% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 100000 | 1000 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 134M | 17.2B | 1% |
Annual Yield % from dividends | 1.39 | 0.84 | 165% |
Returns for 1 year | 16.95 | -4.63 | -366% |
Returns for 3 years | 35.67 | 20.78 | 172% |
Returns for 5 years | 70.13 | 53.86 | 130% |
Returns for 10 years | 139.04 | 78.48 | 177% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 37.15 | 0.33 | +0.90% |
Fidelity Advisor Biotechnology I | |||
RYCSX | 48.59 | 0.22 | +0.45% |
Rydex Telecommunications C | |||
ANTGX | 10.96 | 0.04 | +0.37% |
American Century Non-US Intrs Val G | |||
KGDIX | 34.88 | 0.10 | +0.29% |
DWS Global Small Cap Inst | |||
CSXRX | 57.59 | 0.11 | +0.19% |
Calvert US Large Cap Core Rspnb Idx R6 |